Krsnaa Diagnostics Limited (NSE:KRSNAA)
India · Delayed Price · Currency is INR 552.90
-11.50 (-2.04%)
Sep 11, 2026, 3:29 PM IST
Krsnaa Diagnostics Market Cap
Krsnaa Diagnostics has a market cap or net worth of 17.84 billion as of September 14, 2026. Its market cap has decreased by -34.94% in one year.
Market Cap
17.84B
Enterprise Value
19.58B
Revenue
8.41B
Ranking
n/a
PE Ratio
18.54
Stock Price
552.90
ChartMarket Cap Chart
Since August 16, 2021, Krsnaa Diagnostics's market cap has decreased from 30.99B to 17.84B, a decrease of -42.42%. That is a compound annual growth rate of -10.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 17.84B | -23.75% |
| Dec 31, 2025 | 23.40B | -18.16% |
| Dec 31, 2024 | 28.59B | 25.42% |
| Dec 29, 2023 | 22.80B | 57.53% |
| Dec 30, 2022 | 14.47B | -37.50% |
| Dec 31, 2021 | 23.15B | -25.28% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.41T |
| Divi's Laboratories | 2.47T |
| Apollo Hospitals Enterprise | 1.27T |
| Lenskart Solutions | 1.19T |
| Beta Drugs | 21.48B |
| Accent Microcell | 17.41B |
| Suraksha Diagnostic | 16.86B |
| Tarsons Products | 16.56B |